Identification of novel peptide motifs in the serpin maspin that affect vascular smooth muscle cell function

S E Jenkinson1, L J Brown2, J Ombor2

  • 1Department of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne NE1 8ST, UK; Institute of Cardiovascular Sciences, Institute for Biomedical Research, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

Insights

New maspin peptides, specifically S4B and S5B, effectively reduce vascular smooth muscle cell (VSMC) migration, invasion, and proliferation, while enhancing adhesion, suggesting anti-atherogenic potential.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Maspin, a serpin family member, influences cell migration and survival.
  • Previous studies identified bioactivity in maspin's G-helix domain peptides.
  • Vascular smooth muscle cell (VSMC) behaviors are critical in atherosclerotic plaque development.

Purpose of the Study:

  • To investigate the anti-atherogenic properties of novel maspin-derived peptides on VSMCs.
  • To identify specific maspin structural moieties that impact VSMC functions.
  • To explore the mechanistic pathways involved in maspin peptide activity.

Main Methods:

  • Design and synthesis of 18 new maspin-derived peptides (>10 amino acids).
  • Functional assays assessing VSMC migration, invasion, adhesion, and proliferation.
  • Screening of novel peptides alongside existing G-helix peptides.
  • Mechanistic studies involving ERK1/2 and AMPK signaling pathways.

Main Results:

  • Maspin strand 4 and 5 of beta sheet B (S4B and S5B) peptides significantly reduced VSMC migration, invasion, and proliferation.
  • These S4B and S5B peptides also increased VSMC adhesion.
  • A combined peptide potentiated these effects, and a 7-mer peptide contained essential functional elements.
  • Evidence suggests S4B and S5B act via ERK1/2 and AMPK pathways.

Conclusions:

  • Maspin strand 4 and 5 of beta sheet B (S4B and S5B) are key functional domains with anti-atherogenic potential.
  • These maspin peptides directly modulate VSMC behavior, impacting key processes in atherosclerosis.
  • The findings reveal a novel mechanism involving ERK1/2 and AMPK signaling for maspin peptide activity in VSMCs.